Tumor models that showed predominant anti-tumor neutrophil function are characterized by relatively high tumor cell production of CXCL2 and other chemokines together with G-CSF/GM-CSF, resulting in the preferential accumulation of activated neutrophils on the expense of other immune cells [60,61]. The gene discussed is CXCL2; the disease is neoplasm.